Protein Kinase Inhibitors: all 15,766 studies that test it

Page 140 of 158. Open to participants first (2,605), then studies with results posted, then the rest; newest registration first within each.

• Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00962312Phase 2
• Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With GlioblastomaCompletedNCT00960492Phase 1
• Phase I Study to Investigate Pharmacokinetics and Safety of BAY73-4506 in Asian (Japanese) Patients With Solid Tumors.CompletedNCT00960258Phase 1
• A Study of ARRY-438162 (MEK162) in Patients With Advanced CancerCompletedNCT00959127Phase 1
• Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast CancerCompletedNCT00958971Phase 2
• Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL)WithdrawnNCT00957320Phase 1
• Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)CompletedNCT00956436Phase 1
• A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer SubjectsCompletedNCT00955773Phase 1
• Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT00955695Phase 3
• Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)CompletedNCT00955149Phase 1
• Maintenance Study on the Long Term Safety of XL999CompletedNCT00955084Phase 1
• Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung CancerCompletedNCT00954278Phase 1
• Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck CancerCompletedNCT00954226Phase 1
• Sunitinib Malate in Treating Patients With Small Cell Lung CancerTerminatedNCT00953459Phase 2
• Study Evaluating The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib In Healthy SubjectsCompletedNCT00952913Phase 1
• A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric CancerCompletedNCT00952497Phase 2
• CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid TumorsCompletedNCT00949624Phase 1
• Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast CancerCompletedNCT00949598Phase 3
• A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the UrotheliumStatus unknownNCT00949455Phase 2/3
• Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00949182Phase 2
• Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral MicrodialysisWithdrawnNCT00949026Phase 1
• Study of TAK-733 in Adult Patients With Advanced Nonhematologic MalignanciesCompletedNCT00948467Phase 1
• Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate CancerCompletedNCT00943956Phase 1
• Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 MutationsCompletedNCT00943943Phase 1
• Sunitinib Malate in Treating Patients With Kidney CancerCompletedNCT00943839Not applicable
• 4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT00943449Phase 2
• Temsirolimus in Recurrent Primary Central Nervous System (CNS) LymphomaStatus unknownNCT00942747Phase 2
• Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00942682Phase 1
• A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal TumorsCompletedNCT00940563Phase 2
• Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic LeukemiaCompletedNCT00940524Phase 1
• Sirolimus and Cetuximab in Advanced MalignanciesCompletedNCT00940381Phase 1
• Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract CancersCompletedNCT00939848Phase 2/3
• TTP607 in Refractory Solid MalignanciesWithdrawnNCT00939172Phase 1
• Safety and Tolerability Study of AZD7762 in Combination With GemcitabineTerminatedNCT00937664Phase 1
• Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerTerminatedNCT00937482Phase 1
• S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid TumorsWithdrawnNCT00937417Phase 1
• Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by SurgeryWithdrawnNCT00936832Phase 2
• Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)CompletedNCT00935987Phase 1/2
• RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck CancerCompletedNCT00935961Phase 1
• Study of TAK-901 in Adults With Advanced Solid Tumors or LymphomaCompletedNCT00935844Phase 1
• Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRICompletedNCT00934882Phase 1
• Study Comparing Two Different Tablet Formulations Of BosutinibCompletedNCT00934674Phase 1
• Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung CancerWithdrawnNCT00934076Phase 1
• Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion ChemotherapyCompletedNCT00933816Phase 1/2
• Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial CarcinomaTerminatedNCT00933374Phase 2
• Study Evaluating The Effect Of A High-Fat Meal On The Pharmacokinetics Of NeratinibWithdrawnNCT00932464Phase 1
• Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast CancerStatus unknownNCT00931450Phase 1/2
• Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast CancerStatus unknownNCT00930475Phase 1/2
• Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell CarcinomaTerminatedNCT00930345Phase 4
• Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to TreatmentCompletedNCT00929903Phase 1
• Topical Rapamycin for FibrofolliculomasCompletedNCT00928798Phase 3
• Imatinib in Patients With Desmoid Tumor and ChondrosarcomaCompletedNCT00928525Phase 2
• RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant NeoplasmsCompletedNCT00927966Phase 1
• Study to Assess the Safety and Tolerability of AZD1152 in Combination With Low Dose Cytosine Arabinoside (LDAC)CompletedNCT00926731Phase 1
• Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only RelapseTerminatedNCT00926107Phase 2
• A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical CarcinomaCompletedNCT00924989Phase 3
• Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic CancerCompletedNCT00922896Phase 2
• Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase InhibitorCompletedNCT00922584Phase 2
• Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate CancerWithdrawnNCT00922129Phase 2/3
• A Study of E7050 Administered Orally to Patients With Advanced Solid TumorsCompletedNCT00921869Phase 1
• Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid TumorCompletedNCT00921336Phase 1
• XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + DasatinibCompletedNCT00920868Phase 1
• A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795CompletedNCT00920257Phase 1
• Safety Study of Foretinib (GSK1363089) in Adults With Liver CancerCompletedNCT00920192Phase 1
• Exemestane (Aromasine) + Tamoxifen - Breast Neo-AdjuvantCompletedNCT00919399Phase 2
• Axitinib Pharmacokinetics in Chinese Healthy VolunteersCompletedNCT00919204Phase 1
• Food Effect Study Of AG-013736 In Healthy VolunteersCompletedNCT00918632Phase 1
• Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)CompletedNCT00914121Phase 1
• Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid ArthritisCompletedNCT00913432Phase 2
• Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young WomenStatus unknownNCT00912548Phase 3
• Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast CancerCompletedNCT00912275Phase 1/2
• PTC299 for Treatment of Neurofibromatosis Type 2TerminatedNCT00911248Phase 2
• Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to TreatmentCompletedNCT00909831Phase 1
• Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCCCompletedNCT00908752Phase 3
• Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy RegimenStatus unknownNCT00908336Phase 2
• Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic MalignanciesCompletedNCT00908167Phase 1
• Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid TumorsTerminatedNCT00908024Phase 1/2
• A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid TumorsCompletedNCT00907205Phase 1
• Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00906360Phase 1
• Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High RiskCompletedNCT00906334Phase 2
• A Bioequivalence Study Of AG-013736 Tablets In Healthy VolunteersCompletedNCT00905814Phase 1
• Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaTerminatedNCT00905398Phase 1/2
• Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological MalignanciesCompletedNCT00904787Phase 1
• Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive MeningiomaStatus unknownNCT00904735Phase 2
• An Explorative Study on the Pharmacokinetics and Pharmacodynamics of Sunitinib in Healthy VolunteersCompletedNCT00904657Phase 1
• An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation StatusCompletedNCT00903734Phase 1
• Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung AdenocarcinomaStatus unknownNCT00903292Not applicable
• Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal TransplantationStatus unknownNCT00903188Phase 4
• A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)CompletedNCT00902200Phase 2
• Tarceva/Rapamycin for Children With Low-grade Gliomas With or Without Neurofibromatosis Type 1 (NF1)CompletedNCT00901849Phase 1
• Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck CancerCompletedNCT00899054Phase 1/2
• Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in JapanCompletedNCT00898716Phase 1
• Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic CancerCompletedNCT00898287Phase 1/2
• Studying Different Formulations of SR13668 in Healthy VolunteersCompletedNCT00896207Phase 1
• Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer PatientsStatus unknownNCT00896155Phase 3
• Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed GlioblastomaTerminatedNCT00895960Phase 1
• Study of Erlotinib in Combination With BortezomibCompletedNCT00895687Phase 1
• Erlotinib in Combination With CetuximabCompletedNCT00895362Phase 1
• Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid LeukemiaTerminatedNCT00895297Phase 2
• The Effects of Oral Curcumin on Heme Oxygenase-1 (HO-1) in Healthy Male SubjectsCompletedNCT00895167Phase 1

← Protein Kinase Inhibitors overview